| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/1996 | WO1996009823A1 Hypoglycemic agent from cryptolepis |
| 04/04/1996 | WO1996009821A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009820A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009819A1 Inhibitor for bone resorption by osteoclast |
| 04/04/1996 | WO1996009818A1 Endothelin receptor antagonists for the treatment of emesis |
| 04/04/1996 | WO1996009817A1 Method for sleep induction |
| 04/04/1996 | WO1996009810A1 Methods for enhancing melanin synthesis in melanocytes using diacylglycerols and uses thereof |
| 04/04/1996 | WO1996009805A2 Chitosan induced immunopotentiation |
| 04/04/1996 | WO1996009764A1 Method, compositions, and apparatus for treating and preventing respiratory viral infections |
| 04/04/1996 | WO1996009759A1 Non-cytotoxic wound-cleansing compositions |
| 04/04/1996 | WO1996004323A3 Gas phase production of polydienes |
| 04/04/1996 | DE4441483C1 Use of bio-assimilated boron cpds. |
| 04/04/1996 | DE4434877A1 Verfahren zur Herstellung von Stärkeabbauprodukten A process for the production of starch degradation products |
| 04/04/1996 | DE19536246A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | DE19536245A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | DE19536244A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | CA2275137A1 Processes for the preparation of (e)-2-(fluoromethylene)-4-(4-fluorophenyl)butylamine and alkali metal salts of diformylamide |
| 04/04/1996 | CA2275136A1 Processes for the preparation of (e)-2-(fluoromethylene)-4-(4-fluorophenyl)butylamine and alkalimetal salts of diformylamide |
| 04/04/1996 | CA2201355A1 Method of producing starch decomposition products |
| 04/04/1996 | CA2201350A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2201349A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2201328A1 Sterol compositions from pulping soap |
| 04/04/1996 | CA2201140A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
| 04/04/1996 | CA2200858A1 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 04/04/1996 | CA2200550A1 Chitosan induced immunopotentiation |
| 04/04/1996 | CA2200436A1 Combination therapy for hypercholesterolemia |
| 04/04/1996 | CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use |
| 04/04/1996 | CA2200208A1 Method for sleep induction |
| 04/04/1996 | CA2199043A1 Novel androstanes for inducing hypothalamic effects |
| 04/04/1996 | CA2199009A1 Processes for the preparation of (e)-2-fluoromethylene-4-(4-fluorophenyl) butylamine and alkali metal salts of diformylamide |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | CA2197471A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 04/03/1996 | EP0704526A1 hTFIIIA gene |
| 04/03/1996 | EP0704448A1 Heterocyclic substituted imidazolidines, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 04/03/1996 | EP0704445A1 Preparation of N-9 substituted guanine compounds |
| 04/03/1996 | EP0704443A2 Quinolone and naphthyridone carboxylic acid derivatives |
| 04/03/1996 | EP0704437A2 Red-shifted tris-aryl-s-triazines and compositions stabilized therewith |
| 04/03/1996 | EP0704434A1 6-Amino-1,4-dihydropyridines and their use as selective k-channel modulators |
| 04/03/1996 | EP0704431A2 Ortho-substituted benzoic acid derivatives |
| 04/03/1996 | EP0704220A1 Use of medicine containing beta interferon |
| 04/03/1996 | EP0704217A2 Method for vascular embolization and vascular embolizing agent |
| 04/03/1996 | EP0704216A1 Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration |
| 04/03/1996 | EP0704215A2 Inhibitor of vascular permeability enhancer |
| 04/03/1996 | EP0704214A1 Process for obtaining pure nizatidine |
| 04/03/1996 | EP0704213A1 Dermatologic compositions containing fatty-acid glycerides for the treatment of superinfections |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0704211A2 Preventive or alleviating agent for medical symptoms caused by delayed allergy reactions |
| 04/03/1996 | EP0704210A2 Use of an agonist of a receptor associated to a chloride channel in the treatment of wrinkles |
| 04/03/1996 | EP0704209A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
| 04/03/1996 | EP0704206A1 Pharmaceutical composition |
| 04/03/1996 | EP0704202A1 Anti-cariogenic agent |
| 04/03/1996 | EP0704057A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 04/03/1996 | EP0703988A1 Mesothelial cell gene therapy |
| 04/03/1996 | EP0703980A1 Intracellular binding proteins and use thereof |
| 04/03/1996 | EP0703979A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
| 04/03/1996 | EP0703954A1 Polyphenol derivative compositions and preparation thereof |
| 04/03/1996 | EP0703925A1 Production of antibody fragments |
| 04/03/1996 | EP0703919A1 Phosphosuccinic acid derivatives and their use as medicaments |
| 04/03/1996 | EP0703917A1 Indolocarbazole compound useful as proteinkinase c inhibitor |
| 04/03/1996 | EP0703916A1 14-substituted marcfortines and derivatives useful as antiparasitic agents |
| 04/03/1996 | EP0703915A1 Heterocyclic chemistry |
| 04/03/1996 | EP0703914A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist |
| 04/03/1996 | EP0703910A1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
| 04/03/1996 | EP0703909A1 $g(D)?6,7 -TAXOLS ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 04/03/1996 | EP0703908A1 Analgesic dibenzoxazepines and dibenzothiazepines |
| 04/03/1996 | EP0703905A1 Inhibitors of farnesyl-protein transferase |
| 04/03/1996 | EP0703904A1 Pyrimidine cyanoguanidines as k-channel blockers |
| 04/03/1996 | EP0703902A1 Piperidine derivatives and process for their production |
| 04/03/1996 | EP0703901A1 1-substituted isatin and oxindole derivatives as inhibitors of acetylcholinesterase |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | EP0703893A1 Salts of 2-(3-benzoylphenyl) propionic acid with achiral and chiral organic bases and pharmaceutical compositions thereof |
| 04/03/1996 | EP0703787A1 Cell growth regulators |
| 04/03/1996 | EP0703782A1 H2-antagonists as immune stimulants in bacterial infections of cattle or swine |
| 04/03/1996 | EP0703781A1 Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease |
| 04/03/1996 | EP0703780A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 04/03/1996 | EP0703774A1 High foaming oral composition |
| 04/03/1996 | EP0703732A1 Food and/or pharmaceutical composition having a low polyamine content |
| 04/03/1996 | EP0703731A1 Food and/or pharmaceutical composition having a low polyamine content, and therapeutical uses thereof |
| 04/03/1996 | EP0703725A1 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes |
| 04/03/1996 | EP0623131B1 Alkyl derivatives of trazodone with cns activity |
| 04/03/1996 | EP0539503B1 Excitatory amino acid antagonists |
| 04/03/1996 | EP0535091B1 Osteoinductive pharmaceutical formulations |
| 04/03/1996 | EP0490891B1 Drug containing matrix |
| 04/03/1996 | EP0478715B1 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1996 | EP0458861B1 Composition for reparation and prevention of fibrotic lesions |
| 04/03/1996 | EP0445280B1 Therapeutic agent and method of inhibiting vascularization of tumors |
| 04/03/1996 | EP0426714B1 Acetylenic imidazoles having central nervous system activity |
| 04/03/1996 | EP0328589B1 Tetra-aza macrocycles and metal complexes thereof |
| 04/03/1996 | CN1119869A N-alkyl-2-substituted ATP analogues |
| 04/03/1996 | CN1119867A 头孢菌素衍生物 Cephalosporin derivatives |
| 04/03/1996 | CN1119866A Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno|2,3-b¨thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 04/03/1996 | CN1119863A Imidazopyridines and their use in treating gastrointestinal diseases |
| 04/03/1996 | CN1119861A 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 04/03/1996 | CN1119860A Method for purifying taxoids |
| 04/03/1996 | CN1119858A New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 04/03/1996 | CN1119856A Inhibitors of HIV reverse transcriptase |
| 04/03/1996 | CN1119854A Acylfulvene analogues as antitumor agents |
| 04/03/1996 | CN1119830A Antisense inhibition of C-MYC to modulate the proliferation of smooth muscle cells |
| 04/03/1996 | CN1119829A Vaccine compositions containing 3-O deacylated monophosphoryl lipid a |
| 04/03/1996 | CN1119647A 6-membered nitrogen-containing heteroaryl-oxazolidinones |